We are delighted to announce today that IntraBio’s Co-Founding Scientist Professor Frances Platt has been elected a Fellow of The Royal Society. Professor Platt joins 52 distinguished scientists who were honoured today with their election for their exceptional contributions to science.
Professor Platt is a Professor of Biochemistry and Pharmacology and the Head of the Department of Pharmacology at the University of Oxford. Oxford’s Department of Pharmacology has been ranked the #1 in the world by QS World University Rankings since 2018.
Professor Platt’s research focuses on the biology and pathobiology of glycosphingolipids and lysosomal storage disorders. This research led to the development of miglustat for the treatment of glycosphingolipid lysosomal storage diseases including Gaucher disease and Niemann-Pick disease type C. Her research has also led to the development of IntraBio’s lead asset IB1001 as a novel treatment for rare and common neurodegenerative diseases and lysosomal storage disorders. Three multinational clinical trials with IB1001 are ongoing for Niemann-Pick disease Type C (NPC, positive data recently reported), GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease), and Ataxia Telangiectasia (A-T).
Professor Platt commented, “It’s a great honour to have been elected and I hope this will help raise awareness about the devastating diseases we work on. I am truly indebted to past and present members of my lab and our collaborators for their outstanding work over the years”.
In addition to being elected to The Royal Society, Professor Platt was elected a Fellow of the Academy of Medical Sciences in 2011, received a Royal Society Wolfson Merit Award in 2013, and in 2016 she became a Wellcome Trust Investigator in Science. She has been awarded the Alan Gordon Memorial Award and the Horst Bickel Award for advances in metabolic disease therapy.
We warmly congratulate Professor Platt on this distinguished and well-deserved honour.
Professor Platt joins IntraBio Co-Founding Scientist Professor Antony Galione as a Fellow of the Royal Society (FRS).